Search This Blog

Thursday, November 30, 2006

FDA Recommends Celebrex

GAITHERSBURG, Md., Nov 29 (Reuters) - Current data do not show Pfizer Inc.'s (PFE.N: Quote, Profile, Research) pain reliever Celebrex is safe for treating rheumatoid arthritis in children, a U.S. advisory panel narrowly ruled on Wednesday.

WASHINGTON (AFX) - A federal advisory panel recommended that Pfizer Inc's Celebrex should be approved to treat rheumatoid arthritis in children, despite worries about long-term safety of the drug, the Wall Street Journal reported. The US Food and Drug Administration's committee of outside experts voted 15-1 in favour of using Celebrex to treat children with the condition, but said that adverse events must be closely monitored in the long term, the paper said.

Would you give your kid a cox-2 inhibitor?

1 comment:

Blogger said...

Did you know that you can shorten your links with Shortest and earn dollars for every click on your short links.